Selected research
Industry Research
Valsartan Tablets Industry Research Report 2026
Market perspective
The global Valsartan Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Valsartan Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Valsartan Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Valsartan Tablets include Alembic, Aurobindo, Cadista, Camber, Lupin, Major, Repackagers, Solco Healthcare and Changzhou Siyao Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Valsartan Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Valsartan Tablets Market by Company
Alembic
Aurobindo
Cadista
Camber
Lupin
Major
Repackagers
Solco Healthcare
Changzhou Siyao Pharmaceutical
Mylan
Teva
Zhejiang Huahai Pharm
Valsartan Tablets Segment by Type
80mg
40mg
320mg
160mg
Valsartan Tablets Segment by Application
Clinic
Hospital
Recovery Center
Valsartan Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valsartan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Valsartan Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Valsartan Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Valsartan Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 80mg
- 40mg
- 320mg
- 160mg
Applications
- Clinic
- Hospital
- Recovery Center
Companies covered
- Alembic
- Aurobindo
- Cadista
- Camber
- Lupin
- Major
- Repackagers
- Solco Healthcare
- Changzhou Siyao Pharmaceutical
- Mylan
- Teva
- Zhejiang Huahai Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Valsartan Tablets Market Size (2021-2032)
- 2.2.2 Global Valsartan Tablets Sales (2021-2032)
- 2.2.3 Global Valsartan Tablets Market Average Price (2021-2032)
- 2.3 Valsartan Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 80mg
- 2.3.3 40mg
- 2.3.4 320mg
- 2.3.5 160mg
- 2.4 Valsartan Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Recovery Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Valsartan Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Valsartan Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Valsartan Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Valsartan Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Valsartan Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Valsartan Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Valsartan Tablets, Product Type & Application
- 3.8 Global Manufacturers of Valsartan Tablets, Established Date
- 3.9 Global Valsartan Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alembic
- 4.1.1 Alembic Company Information
- 4.1.2 Alembic Business Overview
- 4.1.3 Alembic Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alembic Valsartan Tablets Product Portfolio
- 4.1.5 Alembic Recent Developments
- 4.2 Aurobindo
- 4.2.1 Aurobindo Company Information
- 4.2.2 Aurobindo Business Overview
- 4.2.3 Aurobindo Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Aurobindo Valsartan Tablets Product Portfolio
- 4.2.5 Aurobindo Recent Developments
- 4.3 Cadista
- 4.3.1 Cadista Company Information
- 4.3.2 Cadista Business Overview
- 4.3.3 Cadista Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cadista Valsartan Tablets Product Portfolio
- 4.3.5 Cadista Recent Developments
- 4.4 Camber
- 4.4.1 Camber Company Information
- 4.4.2 Camber Business Overview
- 4.4.3 Camber Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Camber Valsartan Tablets Product Portfolio
- 4.4.5 Camber Recent Developments
- 4.5 Lupin
- 4.5.1 Lupin Company Information
- 4.5.2 Lupin Business Overview
- 4.5.3 Lupin Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lupin Valsartan Tablets Product Portfolio
- 4.5.5 Lupin Recent Developments
- 4.6 Major
- 4.6.1 Major Company Information
- 4.6.2 Major Business Overview
- 4.6.3 Major Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Major Valsartan Tablets Product Portfolio
- 4.6.5 Major Recent Developments
- 4.7 Repackagers
- 4.7.1 Repackagers Company Information
- 4.7.2 Repackagers Business Overview
- 4.7.3 Repackagers Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Repackagers Valsartan Tablets Product Portfolio
- 4.7.5 Repackagers Recent Developments
- 4.8 Solco Healthcare
- 4.8.1 Solco Healthcare Company Information
- 4.8.2 Solco Healthcare Business Overview
- 4.8.3 Solco Healthcare Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Solco Healthcare Valsartan Tablets Product Portfolio
- 4.8.5 Solco Healthcare Recent Developments
- 4.9 Changzhou Siyao Pharmaceutical
- 4.9.1 Changzhou Siyao Pharmaceutical Company Information
- 4.9.2 Changzhou Siyao Pharmaceutical Business Overview
- 4.9.3 Changzhou Siyao Pharmaceutical Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio
- 4.9.5 Changzhou Siyao Pharmaceutical Recent Developments
- 4.10 Mylan
- 4.10.1 Mylan Company Information
- 4.10.2 Mylan Business Overview
- 4.10.3 Mylan Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mylan Valsartan Tablets Product Portfolio
- 4.10.5 Mylan Recent Developments
- 4.11 Teva
- 4.11.1 Teva Company Information
- 4.11.2 Teva Business Overview
- 4.11.3 Teva Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Teva Valsartan Tablets Product Portfolio
- 4.11.5 Teva Recent Developments
- 4.12 Zhejiang Huahai Pharm
- 4.12.1 Zhejiang Huahai Pharm Company Information
- 4.12.2 Zhejiang Huahai Pharm Business Overview
- 4.12.3 Zhejiang Huahai Pharm Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio
- 4.12.5 Zhejiang Huahai Pharm Recent Developments
5 Global Valsartan Tablets Market Scenario by Region
- 5.1 Global Valsartan Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Valsartan Tablets Sales by Region: 2021-2032
- 5.2.1 Global Valsartan Tablets Sales by Region: 2021-2026
- 5.2.2 Global Valsartan Tablets Sales by Region: 2027-2032
- 5.3 Global Valsartan Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Valsartan Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Valsartan Tablets Revenue by Region: 2027-2032
- 5.4 North America Valsartan Tablets Market Facts & Figures by Country
- 5.4.1 North America Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Valsartan Tablets Sales by Country (2021-2032)
- 5.4.3 North America Valsartan Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Valsartan Tablets Market Facts & Figures by Country
- 5.5.1 Europe Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Valsartan Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Valsartan Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Valsartan Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Valsartan Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Valsartan Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Valsartan Tablets Market Facts & Figures by Country
- 5.7.1 South America Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Valsartan Tablets Sales by Country (2021-2032)
- 5.7.3 South America Valsartan Tablets Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Valsartan Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Valsartan Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Valsartan Tablets Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Valsartan Tablets Sales by Type (2021-2032)
- 6.1.1 Global Valsartan Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Valsartan Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Valsartan Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Valsartan Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Valsartan Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Valsartan Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Valsartan Tablets Sales by Application (2021-2032)
- 7.1.1 Global Valsartan Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Valsartan Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Valsartan Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Valsartan Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Valsartan Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Valsartan Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Valsartan Tablets Value Chain Analysis
- 8.1.1 Valsartan Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Valsartan Tablets Production Mode & Process
- 8.2 Valsartan Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Valsartan Tablets Distributors
- 8.2.3 Valsartan Tablets Customers
9 Global Valsartan Tablets Analyzing Market Dynamics
- 9.1 Valsartan Tablets Industry Trends
- 9.2 Valsartan Tablets Industry Drivers
- 9.3 Valsartan Tablets Industry Opportunities and Challenges
- 9.4 Valsartan Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst